welcome to the belle capital usa website

Masthead Image

Danong ChenDanong Chen PhD

Technology Council

CEO MetronomX, Houston, TX

Dr. Danong Chen is a seasoned executive with over two decades of experience in corporate strategy and product development and commercialization. She was President and Chief Executive Officer of Tanox, Inc., a Houston based, publicly traded biotherapeutic company, which was one of the largest biotech companies in Texas. During her tenure as the CEO and President, Tanox was acquired by Genentech in 2007 in a transaction valued at about $1 billion. Prior to being named President and CEO, she was Vice President of Strategy and Corporate Development at Tanox, responsible for guiding company strategy, evaluating new product opportunities and potential merger and acquisition transactions, and overseeing annual product prioritization and related budgeting process. Dr. Chen joined Tanox as Associate Director of Strategy in 2002 and between 2002 and 2005 she held increasing responsibilities in areas of Strategy, Corporate and Business Development and Project Management. From April 2008 to Aug 2009, Dr. Chen served as President and Chief Executive Officer of Theranostics Health, Inc., a biotech company focused on developing products for personalized treatments. Prior to joining Tanox, Dr. Chen served as a manager in the health-care practice of Arthur D. Little, Inc., the world's first strategic consulting company with a reputation and emphasis on innovation and technology based/guided strategies. Early in her career, she developed immunoassay-based clinical diagnostics in Shanghai, China and won a bronze medal from the Chinese government for one of the products she developed. As a trained molecular neuroscientist, she has a deep understanding of molecular and cellular interactions as they relate to drug targets and drug candidates in therapeutic product development. Dr. Chen received her Ph.D. in Neuroscience from Baylor College of Medicine in Houston, TX and MBA from Arthur D. Little School of Management in Boston, MA.


NopSec and Qualys Partner to Offer Enhanced Security and Compliance Analytics

New Security Findings--Apple Isn't Immune And Fixing Takes Too Long

List of Female Angel and Early-Stage Investors in Tech

Cardialen Raises Additional $1.5 million

UNopsec Selected for 20 Most Promising Security Companies for 2015

US Bancorp Invests in Finomial Platform

The Top Angels in Tech

20 Lesser Known Angels Crushing it

7 Things Investors Love To See

Do Women Entrepreneurs Invest Differently From Men?

How Belle Capital USA invests in women-run tech startups

Current Motor Rolls Out 'Mini-Fleet' Solar Station And Electric Scooters

President Obama praises Current Motor board member & strategic assembly partner, Andra Rush

Current Motor in MotorWeek

Finomial Finomial Helps Hedge Funds Deploy in the Cloud

Finomial's Automated Solution to Help Relieve FATCA burden

NopSec recognized as 2013 "Emerging Security Vendor" by CRN Magazine

Lessons From a Startup That Got Away

The New Girls Network: Building A Bigger Pie For High-Growth Women-Led Companies

Human Capital, the Doorway to Financial Capital

Betting on Women in STEM

7 Things Investors Love To See

BELLE Managing Director Lauren Flanagan and Advisor Ingrid Vanderveldt Named to 40 Women Over 40 to Watch

Dell's Secret Weapon, Entrepreneur-in-Residence and BELLE advisor, Ingrid Vanderveldt

Current Motor at NAIAS, Detroit Auto Show

Car Talk
Detroit 2013: It's Not Always Easy Being Green

NAIAS 2013: Current Motor Company Scooters

Midwest Energy News
At Detroit auto show, electric vehicles still make a splash

Current Motor's Partnership with Dakkota Integrated Systems Powers Growth Engine

SPINS Acquires Third Solutions

Epson Partners with Third Solutions

Detroit Free Press
Tart Cherry Industry Touts Health Benefits

Lauren Flanagan named to BusinessWeek's Top 25 Angels in Tech